Skip to content
Open·Ingested today, not yet re-verified. Deadlines can change; confirm on the official page.

Nanobody against NPR-C for growth disorder

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Place of performance: Bethesda, MD

View the solicitation

Free. Verify your email, then we send one reminder only.

Posted
Aug 19, 2026
Closes
Aug 28, 2026 (in 9 days)

Get alerted when new contract opportunities like this open.

Checking your account…

Free. Everyone sees new listings after 10 days. Unsubscribe anytime.

At a glance

This is a government contract opportunity posted by HEALTH AND HUMAN SERVICES, DEPARTMENT OF in the research and development in biotechnology (except nanobiotechnology) category. The deadline is August 28, 2026, 10 days from now. Work is performed in Bethesda, MD. This solicitation carries a Small Business Set Aside - Total set-aside.

Classification and identifiers

Industry (NAICS)
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
Product or service (PSC)
Other Professional Services (R499)
Solicitation number
75N98026Q01031
Contracting office
NATIONAL INSTITUTES OF HEALTH OLAO
Set-aside
Small Business Set Aside - Total

Who can apply

Small businessWork performed in Bethesda, MD

Small businesses can apply here. Check the eligibility details below to see if your organization fits.

Small Business Set Aside - Total

About this opportunity

See attached Word document. Project Title: Nanobody against NPR-C for growth disorder 1. Project Overview 1.1 Background We sought to develop nanobodies (VHH) against human NPR-C with high affinity and specificity for future clinical use. These nanobodies could potentially be further developed into therapeutics for treatment of growth disorders such as achondroplasia. 1.2 Main Objectives - generation of antigens needed for immunization - immunization of Alpaca/Ilama with target antigens generated - generation of immunized phage/yeast library and in vitro screening using the library - alternatively, single B-cell screening and sequencing instead of phage/yeast library generation/screening. - downstream functional confirmation of VHH nanobodies binding to target antigens - generation of fina...

Refine this search